Cas no 228271-47-4 (5H,6H,7H,8H,9H-pyrido[3,4-d]azepine)
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine Chemical and Physical Properties
Names and Identifiers
-
- 5H-Pyrido[3,4-d]azepine,6,7,8,9-tetrahydro-
- 6,7,8,9-tetrahydro-5H-pyrido[4,3-d]azepine
- 5H,6H,7H,8H,9H-pyrido[3,4-d]azepine
- SCHEMBL19200207
- 6,7,8,9-Tetrahydro-5H-pyrido[3,4-d]azepine
- 228271-47-4
- SB21517
- CHEMBL52133
- BDBM50143278
-
- Inchi: 1S/C9H12N2/c1-4-10-5-3-9-7-11-6-2-8(1)9/h2,6-7,10H,1,3-5H2
- InChI Key: TYCKRCIGLWSVCK-UHFFFAOYSA-N
- SMILES: N1CCC2C=NC=CC=2CC1
Computed Properties
- Exact Mass: 148.100048391g/mol
- Monoisotopic Mass: 148.100048391g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 125
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.7
- Topological Polar Surface Area: 24.9?2
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-100MG |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 100MG |
¥ 1,683.00 | 2023-04-05 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-250MG |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 250MG |
¥ 2,692.00 | 2023-04-05 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-500MG |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 500MG |
¥ 4,481.00 | 2023-04-05 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-1G |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 1g |
¥ 6,718.00 | 2023-04-05 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-5G |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 5g |
¥ 20,156.00 | 2023-04-05 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-100mg |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 100mg |
¥1681.0 | 2024-04-22 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-250mg |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 250mg |
¥2691.0 | 2024-04-22 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-500mg |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 500mg |
¥4478.0 | 2024-04-22 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-1g |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 1g |
¥6714.0 | 2024-04-22 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBYS1664-100.0mg |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine |
228271-47-4 | 95% | 100.0mg |
¥1681.0000 | 2025-04-11 |
5H,6H,7H,8H,9H-pyrido[3,4-d]azepine Related Literature
-
Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
-
Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411
-
Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
-
Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
-
Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
Additional information on 5H,6H,7H,8H,9H-pyrido[3,4-d]azepine
5H,6H,7H,8H,9H-Pyrido[3,4-d]Azepine: A Comprehensive Overview
5H,6H,7H,8H,9H-Pyrido[3,4-d]azepine, also known by its CAS number 228271-47-4, is a heterocyclic compound that has garnered significant attention in the fields of organic chemistry and materials science. This compound belongs to the class of pyridazepines, which are fused bicyclic systems consisting of a pyridine ring and an azepine ring. The unique electronic properties and structural features of pyrido[3,4-d]azepine make it a promising candidate for various applications in optoelectronics and drug discovery.
Recent studies have highlighted the potential of 5H,6H,7H,8H,9H-pyrido[3,4-d]azepine as a building block for constructing advanced materials with tailored electronic properties. Researchers have explored its ability to form self-assembled monolayers (SAMs) and its role in enhancing the performance of organic light-emitting diodes (OLEDs). The compound's conjugated system allows for efficient charge transport and emission characteristics, making it a valuable component in next-generation display technologies.
In addition to its electronic applications, pyrido[3,4-d]azepine has shown promise in the field of medicinal chemistry. Its structural similarity to certain bioactive compounds has led to investigations into its potential as a scaffold for drug development. Recent studies have demonstrated that derivatives of this compound exhibit modulatory effects on key biological targets associated with neurodegenerative diseases and cancer. These findings underscore the importance of further research into the pharmacological properties of this compound.
The synthesis of 5H,6H,7H,8H,9H-pyrido[3,4-d]azepine typically involves multi-step reactions that require precise control over reaction conditions. One common approach involves the cyclization of appropriately substituted precursors under thermal or photochemical conditions. Recent advancements in catalytic methods have enabled more efficient and selective syntheses of this compound. These improvements have facilitated access to a wider range of derivatives for both academic and industrial applications.
From an environmental perspective, the stability and biodegradability of pyrido[3,d]azepine-based materials are critical considerations for their large-scale deployment. Emerging research has focused on evaluating the environmental impact of these compounds and developing strategies to minimize their ecological footprint. This includes exploring recyclable synthesis pathways and assessing their compatibility with sustainable manufacturing practices.
In conclusion, 5H,6H,7H,8H,9H-pyrido[3,4-d]azepine is a versatile compound with a wide range of potential applications across multiple disciplines. Its unique chemical properties and structural features continue to drive innovative research efforts aimed at unlocking its full potential. As advancements in synthetic methods and material characterization techniques continue to evolve,
we can expect even more exciting developments in the utilization of this remarkable compound.
228271-47-4 (5H,6H,7H,8H,9H-pyrido[3,4-d]azepine) Related Products
- 1000504-51-7(2-(4-Methyl-pyridin-3-yl)ethylamine)
- 31786-18-2(1,2,3,4-tetrahydro-2,6-naphthyridine)
- 108749-08-2(1,2,3,4-tetrahydro-2,7-naphthyridine)
- 1003561-87-2(methyl[2-(pyridin-3-yl)ethyl]amine dihydrochloride)
- 186966-72-3(2,6-Naphthyridine,1,2,3,4-tetrahydro-2-methyl-)
- 19690-13-2(methyl[2-(pyridin-3-yl)ethyl]amine)
- 99516-20-8(ethyl2-(pyridin-4-yl)ethylamine)
- 98336-64-2(4-methyl-1H-Pyrrole-3-ethanamine)
- 5415-00-9((N-[2-(pyridin-3-yl)ethyl]butan-1-amine ))
- 345311-06-0(2-Benzyl-1,2,3,4-tetrahydro-2,6-naphthyridine)